Literature DB >> 19466387

Neurocysticercosis in children.

Pratibha Singhi1, Sunit Singhi.   

Abstract

Neurocysticercosis (NCC) is a common cause of seizures and neurologic disease. Although there may be variable presentations depending on the stage and location of cysts in the nervous system, most children (> 80%) present with seizures particularly partial seizures. About a third of cases have headache and vomiting. Diagnosis is made by either CT or MRI. Single enhancing lesions are the commonest visualization of a scolex confirms the diagnosis. Some cases have multiple cysts with a characteristic starry-sky appearance. Management involves use of anticonvulsants for seizures and steroids for cerebral edema. The use of cysticidal therapy continues to be debated. Controlled studies have shown that cysticidal therapy helps in increased and faster resolution of CT lesions. Improvement in long-term seizure control has not yet been proven. Children with single lesions have a good outcome and seizure recurrence rate is low. Children with multiple lesions have recurrent seizures. Extraparenchymal NCC has a guarded prognosis but it is rare in children. In endemic areas NCC must be considered in the differential diagnosis of seizures and various other neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466387     DOI: 10.1007/s12098-009-0139-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  68 in total

1.  Optimization of the single-day praziquantel therapy for neurocysticercosis.

Authors:  M López-Gómez; N Castro; H Jung; J Sotelo; T Corona
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

2.  Dexamethasone increases plasma levels of albendazole.

Authors:  H Jung; M Hurtado; M T Medina; M Sanchez; J Sotelo
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

3.  Which MRI sequences are best suited to the evaluation of patients with neurocysticercosis?

Authors:  Julio Sotelo
Journal:  Nat Clin Pract Neurol       Date:  2007-12-11

4.  Intramedullary cysticercosis cured with drug treatment. A case report.

Authors:  I Corral; C Quereda; A Moreno; R López-Vélez; J Martínez-San-Millán; A Guerrero; J Sotelo
Journal:  Spine (Phila Pa 1976)       Date:  1996-10-01       Impact factor: 3.468

5.  Short regimen of praziquantel in the treatment of single brain enhancing lesions.

Authors:  E J Pretell; H H Garcia; N Custodio; C Padilla; M Alvarado; R H Gilman; M Martinez
Journal:  Clin Neurol Neurosurg       Date:  2000-12       Impact factor: 1.876

6.  Treating neurocysticercosis medically: a systematic review of randomized, controlled trials.

Authors:  R Salinas; C Counsell; K Prasad; H Gelband; P Garner
Journal:  Trop Med Int Health       Date:  1999-11       Impact factor: 2.622

7.  Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

Authors:  M Cruz; I Cruz; J Horton
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Mar-Apr       Impact factor: 2.184

Review 8.  Imaging findings in neurocysticercosis.

Authors:  Héctor H García; Oscar H Del Brutto
Journal:  Acta Trop       Date:  2003-06       Impact factor: 3.112

9.  Family studies and human leukocyte antigen class II typing in Indian probands with seizures in association with single small enhancing computed tomography lesions.

Authors:  S Jain; M V Padma; U Kanga; N K Mehra; A Puri; M C Maheshwari
Journal:  Epilepsia       Date:  1999-02       Impact factor: 5.864

10.  Albendazole therapy for neurocysticercosis.

Authors:  F Escobedo; P Penagos; J Rodriguez; J Sotelo
Journal:  Arch Intern Med       Date:  1987-04
View more
  12 in total

1.  Taenia saginata metacestode antigenic fractions without affinity to concanavalin A are an important source of specific antigens for the diagnosis of human neurocysticercosis.

Authors:  Heliana B Oliveira; Gleyce A Machado; José R Mineo; Julia M Costa-Cruz
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

2.  Clinical and radiological profile of neurocysticercosis in South Indian children.

Authors:  J Balaji; Meikandan D
Journal:  Indian J Pediatr       Date:  2011-03-12       Impact factor: 1.967

3.  Neurocysticercosis (NCC) with Hydrocephalus, Optic Atrophy and Vision Loss: A Rare Presentation.

Authors:  Nagendra Chaudhary; Shyam Kumar Mahato; Salamat Khan; Santosh Pathak; B D Bhatia
Journal:  J Clin Diagn Res       Date:  2015-02-01

4.  A Stratified Analysis of Clinical Manifestations and Different Diagnostic Methods of Neurocysticercosis-Suspected Tamilian Population Residing in and Around Puducherry.

Authors:  Piriyatharisini Thamilselvan; Krishna Raja Muthuraman; Sheeba Arockiamary Thasan; Gayathri Kasinathan; Jharna Mandal; Subhash Chandra Parija
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 5.  Corticosteroid use in neurocysticercosis.

Authors:  Theodore E Nash; Siddhartha Mahanty; Hector H Garcia
Journal:  Expert Rev Neurother       Date:  2011-08       Impact factor: 4.618

6.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

7.  Changes in the seroprevalence of cysticercosis in suspected patients in Chandigarh, India between 1998 and 2014: analysis of 17 years of data.

Authors:  L J Robertson; H Joshi; K S Utaaker; A Kumar; S Chaudhary; K Goyal; R Sehgal
Journal:  Epidemiol Infect       Date:  2017-01-16       Impact factor: 4.434

Review 8.  Clinical manifestations associated with neurocysticercosis: a systematic review.

Authors:  Hélène Carabin; Patrick Cyaga Ndimubanzi; Christine M Budke; Hai Nguyen; Yingjun Qian; Linda Demetry Cowan; Julie Ann Stoner; Elizabeth Rainwater; Mary Dickey
Journal:  PLoS Negl Trop Dis       Date:  2011-05-24

9.  Time trend of neurocysticercosis in children with seizures in a tertiary hospital of western Nepal.

Authors:  Kalipatnam Seshagiri Rao; Sudhir Adhikari; Eva Gauchan; Brijesh Sathian; Ganesh B K; Sahisnuta Basnet; Prabhat Kumar Tiwari; Namraj Bahadur; Rajnish Mishra
Journal:  PLoS Negl Trop Dis       Date:  2017-05-10

Review 10.  Pediatric neurocysticercosis: current challenges and future prospects.

Authors:  Pratibha Singhi; Arushi Gahlot Saini
Journal:  Pediatric Health Med Ther       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.